Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin

Leukemia. 2020 Apr;34(4):1208-1209. doi: 10.1038/s41375-019-0616-4. Epub 2019 Nov 7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aspirin
  • Humans
  • Myeloproliferative Disorders*
  • Neoplasms, Second Primary*
  • Platelet Aggregation

Substances

  • Aspirin